Evaluation of malignant liver tumors: Biphasic MS-CT versus quantitative contrast harmonic imaging ultrasound

Zeitschrift fur Gastroenterologie

Volumn 47, Issue 12, 2009, Pages 1195-1202

  Clevert, Dirk André ^a   Jung, E M ^b   Stock, K F ^c   Weckbach, S ^a   Feuerbach, S ^b   Reiser, M ^a   Jung, F ^d  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d Centre for Biomaterial Development   (Slovakia)

Author keywords

Colorectal cancer; Liver; Rectal cancer

Indexed keywords

IOPAMIDOL; SONOVUE;

ADULT; AGED; ARTICLE; B SCAN; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DOPPLER FLOWMETRY; DRUG ACCUMULATION; ECHOGRAPHY; FALSE NEGATIVE RESULT; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER ABSCESS; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CYST; LIVER FATTY DEGENERATION; LIVER HEMANGIOMA; LIVER HYPERPLASIA; LIVER METASTASIS; MALE; MULTICENTER STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; QUANTITATIVE CONTRAST ENHANCED HARMONIC IMAGING ULTRASOUND; SENSITIVITY AND SPECIFICITY; TUMOR VASCULARIZATION; TUMOR VOLUME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; PHOSPHOLIPIDS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER;

EID: 75749144650     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1109396     Document Type: Article

References (30)

1. Strobel D, Bernatik T. Diagnostik bei fokalen Leberläsionen. Deutsches Ärzteblatt 2006; 103: 789-793
2. Oldenburg A, Hohmann J, Foert E et al. Detection of hepatic metastases with low MI real time contrast-enhanced sonography and SonoVue. Ultraschall in Med 2005; 26: 277-284
3. Regge D, Campanella D, Anselmetti GC et al. Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma. Clin Radiol 2006; 61: 338-347
4. Bruix J, Sherman M, Llovet JM et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430
5. Bleuzen A, Huang C, Olar M et al. Diagnostic accuracy of contrast-enhanced ultrasound in focal lesions of the liver using cadence contrast pulse sequencing. Ultraschall in Med 2006; 27: 40-48
6. von Herbay A, Haussinger D, Gregor M et al. Characterization and detection of hepatocellular carcinoma (HCC): comparison of the ultrasound contrast agents SonoVue (BR 1) and Levovist (SH U 508A) - comparison of SonoVue and Levovist in HCC. Ultraschall in Med 2007; 28: 168-175
7. Konopke R, Bunk A, Kersting S. The role of contrast-enhanced ultrasound for focal liver lesion detection: an overview. Ultrasound Med Biol 2007; 33: 1515-1526
8. Harvey CJ, Blomley MJ, Eckersley RJ et al. Developments in ultrasound contrast media. Eur Radiol 2001; 11: 675-689 (Review)
9. Michaely HJ, Thomsen HS, Reiser MF et al. Nephrogenic systemic fibrosis (NSF) - implications for radiology. Radiologe 2007; 47: 785-793 (Review)
10. Brenner DJ, Hall EJ. Computed tomography - an increasing source of radiation exposure. N Engl J Med 2007; 357: 2277-2284 (Review)
11. Jung EM, Clevert DA, Schreyer AG et al. Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: A prospective controlled two-center study. World J Gastroenterol 2007; 13: 6356-6364
12. Clevert DA, Bensler S, Stickel M et al. Contrast-enhanced ultrasound eases interpretation of an unclear renal tumor in addition to CT, MRI, and histological findings - a case report in a young patient. Clin Hemorheol Microcirc 2007; 36: 313-318
13. Prantl L, Schreml S, Walter M et al. Evaluation of microcirculation of free flaps of the lower leg by contrast harmonic imaging (CHI) with time intensity curve (TIC) analysis. Clin Hemorheol Microcirc 2008; 39: 343-50
14. Griner H. Selection and interpretation of diagnostic tests and procedures. Annals Int Med 1981; 94: 553-600
15. Linnert K. A review on the methodology for assessing diagnostic tests. Clin Chem 1988; 34: 1379-1386
16. Landis JR, Koch GG. The measurement of abserve agreement for ategorial data. Biometrics 1977; 33: 159-174
17. Hohmann J, Albrecht T, Oldenburg A et al. Liver metastases in cancer: detection with contrast-enhanced ultrasonography. Abdom Imaging 2004; 29: 669-681
18. Albrecht T, Blomley MJ, Burns PN et al. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 2003; 227: 361-370
19. Bartolozzi C, Donati F, Cioni D et al. Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT. Eur Radiol 2004; 14: 14-20
20. Boozari B, Lotz J, Galanski M et al. Diagnostic imaging of liver tumours: Current status. Internist 2007; 48: 8-20
21. Regge D, Campanella D, Anselmetti GC et al. Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma. Clin Radiol 2006; 61: 338-347
22. Zhao H, Yao JL, Wang Y et al. Detection of small hepatocellular carcinoma. Comparison of dynamic enhancement magnetic resonance imaging and multiphase multirow-detector helical CT scanning. World J Gastroenterol 2007; 13: 1252-1256
23. Celli N, Gaiani S, Piscaglia F et al. Characterization of liver lesions by real-time contrast-enhanced ultrasonography. Eur J Gastroenterol Hepatol 2007; 19: 3-14
24. Bleuzen A, Huang C, Olar M et al. Diagnostic accuracy of contrast-enhanced ultrasound in focal lesions of the liver using cadence contrast pulse sequencing. Ultraschall in Med 2006; 27: 40-48
25. Jung EM, Kubale R, Jungius KP et al. Vascularization of liver tumors - preliminary results with coded harmonic angio (CHA), phase inversion imaging, 3D power Doppler, and contrast medium-enhanced B-flow with second generation contrast agent (Optison). Clin Hemorheol Microcirc 2006; 34: 483-497
26. Jung EM, Kubale R, Jungius KP. Vascularization and perfusion of hepatocellular carcinoma: assessment with contrast-enhanced ultrasound using perflutren protein-type A microspheres. Clin Hemorheol Microcirc 2005; 33: 63-73
27. McLarney JK, Rucker FT, Bender GN et al. Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation. Radiographics 1999; 19: 453-471
28. Mansuri D, Van Nhieu JT, Couanet D et al. Fibrolamellar hepatocellular carcinoma: a case report with cytological features in a sixteen-year-old girl. Diagn Cytopathol 2006; 34: 568-571
29. Mandry D, Bressenot A, Galloy MA et al. Contrast-enhanced ultrasound in fibrolamellar hepatocellular carcinoma: a case report. Ultraschall in Med 2007; 28: 547-552
30. Schreyer AG, Finkenzeller T, Gössmann H et al. Microcirculation and perfusion with contrast-enhanced ultrasound (CEUS) in Crohn's disease: first results with linear contrast harmonic imaging (CHI). Clin Hemorheol Microcirc 2008; 40: 143-155